OpenAI and Amazon Web Services strike a $38 billion, seven-year partnership to provide OpenAI with massive computing power for its AI workloads.
FDA rejects UniQure's AMT-130 data, sending shares tumbling as the company scrambles to find a path to approval.
Global tech stocks show mixed performance as investors navigate economic uncertainties, focusing on companies with solid fundamentals and emerging technology trends.
OpenAI and Amazon Web Services strike a $38 billion, seven-year partnership to provide OpenAI with massive computing power for its AI workloads.
FDA rejects UniQure's AMT-130 data, sending shares tumbling as the company scrambles to find a path to approval.
Global tech stocks show mixed performance as investors navigate economic uncertainties, focusing on companies with solid fundamentals and emerging technology trends.